熱門資訊> 正文
沃尔格林将支付1.068亿美元来解决司法部超额计费的索赔
2024-09-14 03:42
- 沃爾格林-聯合博姿(WBA) 0
- 高宏集團(COWN) 0
- 易康(EHTH) 0
- The U.S. Department of Justice announced Friday that Walgreens Boots Alliance (NASDAQ:WBA) has agreed to pay $106.8M to settle its allegations that the pharmacy chain operator billed government health care programs for prescriptions it never dispensed.
- The alleged violations took place between 2009 and 2020 when Walgreens (WBA) submitted false claims for payments to Medicare, Medicaid, and other federal healthcare programs.
- The DoJ alleged that the Deerfield, Illinois, company obtained payments twice after restocking and reselling prescriptions it processed for federal health care programs, but their beneficiaries never picked up.
- “As a result, Walgreens received tens of millions of dollars for prescriptions that it never actually provided to health care beneficiaries,” the agency added.
- “This settlement marks another major achievement in our ongoing commitment to combat healthcare fraud,” said Roger B. Handberg U.S. Attorney for the Middle District of Florida.
More on Walgreens Boots Alliance
- Walgreens Boots Alliance, Inc. (WBA) TD Cowen 9th Annual FutureHealth Conference (Transcript)
- Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses
- Walgreens Is Imploding: Value Stock Or Value Trap?
- Walgreens, Hims stocks drop as Lilly rolls out cheap weight-loss drugs
- Retailers charge cash-back fees to consumers on smaller supply of free cash access points: CFPB
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
